Cargando…

Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer’s disease

Apolipoproteins C-I, C-II, and C-III interact with ApoE to regulate lipoprotein metabolism and contribute to Alzheimer's disease pathophysiology. In plasma, apoC-I and C-II exist as truncated isoforms, while apoC-III exhibits multiple glycoforms. This study aimed to 1) delineate apoC-I, C-II, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yueming, Meuret, Cristiana, Martinez, Ashley, Yassine, Hussein N., Nedelkov, Dobrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859854/ https://www.ncbi.nlm.nih.gov/pubmed/33518512 http://dx.doi.org/10.1194/jlr.RA120000919

Ejemplares similares

Simple and Fast Assay for Apolipoprotein E Phenotyping and Glycotyping: Discovering Isoform-Specific Glycosylation in Plasma and Cerebrospinal Fluid
por: Hu, Yueming, et al.
Publicado: (2020)

An association of CSF apolipoprotein E glycosylation and amyloid-beta 42 in individuals who carry the APOE4 allele
por: Meuret, Cristiana J., et al.
Publicado: (2023)

Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis
por: Koska, Juraj, et al.
Publicado: (2022)

The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides
por: Yassine, Hussein N., et al.
Publicado: (2015)

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk
por: Orsi, Fernanda A, et al.
Publicado: (2019)

Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer
por: Wang, Min, et al.
Publicado: (2019)

Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes
por: Nedelkov, Dobrin
Publicado: (2017)

Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III
por: Chen, Wei-Ling, et al.
Publicado: (2021)

The association of plasma cystatin C proteoforms with diabetic chronic kidney disease
por: Yassine, Hussein N., et al.
Publicado: (2016)

Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E
por: Millar, John S., et al.
Publicado: (2017)

Amyloid Triangles, Squares, and Loops of Apolipoprotein C-III
por: de Messieres, Michel, et al.
Publicado: (2014)

Apolipoprotein C-III in patients with systemic lupus erythematosus
por: Martín-González, Candelaria, et al.
Publicado: (2022)

Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee
por: Wang, Wenyu, et al.
Publicado: (2017)

Clusterin/apolipoprotein J, its isoforms and Alzheimer's disease
por: Milinkeviciute, Giedre, et al.
Publicado: (2023)

Overexpression of apolipoprotein C‐III decreases secretion of dietary triglyceride into lymph
por: Wang, Fei, et al.
Publicado: (2014)

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism
por: Luo, Mengdie, et al.
Publicado: (2016)

Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels
por: Ruixing, Yin, et al.
Publicado: (2010)

Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's Disease
por: Watanabe, Yumi, et al.
Publicado: (2020)

Apolipoprotein E in VLDL and LDL With Apolipoprotein C‐III is Associated With a Lower Risk of Coronary Heart Disease
por: Mendivil, Carlos O., et al.
Publicado: (2013)

Production of Apolipoprotein C-III Knockout Rabbits using Zinc Finger Nucleases
por: Yang, Dongshan, et al.
Publicado: (2013)

Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies
por: Dib, Israa, et al.
Publicado: (2021)

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk
por: Tardif, Jean-Claude, et al.
Publicado: (2022)

Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome
por: Ooi, Esther M.M., et al.
Publicado: (2008)

Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases
por: Van Valkenburgh, Juno, et al.
Publicado: (2021)

Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays
por: Cohen, Meital, et al.
Publicado: (2011)

Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma
por: Xue, A, et al.
Publicado: (2012)

Identification of Apolipoprotein C-I as a Potential Wilms’ Tumor Marker after Excluding Inflammatory Factors
por: Zhang, Junjie, et al.
Publicado: (2014)

Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis
por: Martín-González, Candelaria, et al.
Publicado: (2022)

Apolipoprotein C‐III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria
por: Jansson Sigfrids, Fanny, et al.
Publicado: (2021)

C-reactive protein isoforms as prognostic markers of COVID-19 severity
por: Molins, Blanca, et al.
Publicado: (2023)

Impact of apolipoprotein E isoforms on sporadic Alzheimer’s disease: beyond the role of amyloid beta
por: Lozupone, Madia, et al.
Publicado: (2023)

Association between apolipoprotein C3 Sst I, T-455C, C-482T and C1100T polymorphisms and risk of coronary heart disease
por: Lin, Bin, et al.
Publicado: (2014)

How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression
por: Rajab, Ibraheem M., et al.
Publicado: (2020)

Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
por: Lohani, Sadichhya, et al.
Publicado: (2016)

Detection of apolipoprotein C in human and rat enterocytes
Publicado: (1980)

Lipids and apolipoproteins C-III and E among treatment-naïve and treatment-experienced persons with HIV in Nigeria
por: Okunorobo, Mercy N., et al.
Publicado: (2023)

Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation
por: Cudaback, Eiron, et al.
Publicado: (2012)

Differentially charged isoforms of apolipoprotein E from human blood are potential biomarkers of Alzheimer’s disease
por: Alzate, Oscar, et al.
Publicado: (2014)

Apolipoprotein C3 and apolipoprotein B colocalize in proximity to macrophages in atherosclerotic lesions in diabetes
por: Kanter, Jenny E., et al.
Publicado: (2020)

Mass Spectrometry Quantification Revealed Accumulation of C-Terminal Fragment of Apolipoprotein E in the Alzheimer's Frontal Cortex
por: Wang, Meiyao, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_91558m2dliullqdocrnres5n0f